Breaking News
Subscribe Now 0
🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.
Pick Stocks with AI
Close

Qiagen NV (QIA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
40.160 +0.430    +1.08%
23:13:58 - Real-time derived data. Currency in EUR
  • Prev. Close: 39.730
  • Open: 39.705
  • Day's Range: 39.700 - 40.380
Type:  Equity
Market:  Germany
ISIN:  NL0012169213 
WKN:  A400D5
Qiagen 40.160 +0.430 +1.08%

Qiagen NV Company Profile

 
Get an in-depth profile of Qiagen NV, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

5900

Equity Type

ORD

Qiagen N.V. offers sample to insight solutions that transform biological materials into molecular insights. The company provides sample technology consumables, such as nucleic stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID and forensics assay consumables, such as STR assays for human ID, and assays for food contamination; PCR instruments include digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It also offers predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a collaboration with the U.S. FBI; and with Bio-Manguinhos/Fiocruz to detect malaria and dengue. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Contact Information

Address Hulsterweg 82
Venlo, 5912 PL
Netherlands
Phone 31 77 355 6600
Fax -

Top Executives

Name Age Since Title
Stephane Bancel 48 2013 Independent Supervisory Director
Lawrence A. Rosen 64 2013 Independent Chairman of Supervisory Board
Metin Colpan 69 1985 Independent Member of the Supervisory Board & Vice Chair of the Scientific Advisory Board
Toralf A. Haag 58 2021 Independent Member of the Supervisory Board
Elaine R. Mardis 62 2014 Independent Member of the Supervisory Board
Elizabeth Edith Tallett 75 2011 Independent Member of the Supervisory Board
Rick A. Bright 58 - Member of Scientific Advisory Board
Patrice Nordmann - - Member of the Scientific Advisory Board
Ross L. Levine 52 2016 Independent Member of the Supervisory Board & Chair of the Scientific Advisory Board
Neville Sanjana - - Member of the Scientific Advisory Board
Sarah A. Polonius-Teichmann - - Member of the Scientific Advisory Board
Eva Pisa 70 2022 Independent Member of the Supervisory Board
Eva van Pelt 59 2024 Independent Member of the Supervisory Board
Peter Klaus Kaspar - - Member of the Scientific Advisory Board
Bert van Meurs 63 2024 Independent Member of the Supervisory Board
Stephen H. Rusckowski 67 2023 Independent Member of Supervisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

QIA Comments

Write your thoughts about Qiagen NV
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email